Search results

Selected filters:

Patent Pools
Analysis

Article type

Topic

Sector

Regions

Year

56 results found for your search

Sort options
05 July 2019

Get ready for the first CRISPR patent pool

In an exclusive interview, MPEG LA’s Kristin Neuman says that a pool is on its way despite the UCal v Broad stand-off and talks about the future of licensing in biotech’s ‘golden age’

05 July 2019

As Sisvel files suit against Dell more light is thrown on Provenance’s ongoing evolution

Licensing platform might be contemplating own assertion campaign in a search for alternative ways to generate revenue from huge portfolio

28 June 2019

New battle in CRISPR patent war adds to the uncertainty surrounding the technology

New interference proceeding gives the University of California another shot at claiming exclusive rights to CRISPR-Cas9 gene-editing in human, animal and plant cells

28 June 2019

Politics, money could temper Chinese interest in Intel auction

A few years ago, it might have been different. But political, legal and economic uncertainty may combine to keep firms like Huawei and ZTE out of the running for Intel’s wireless IP

27 June 2019

Low on encumbrances and relatively young, the Intel patents look ripe for sale - but will that be enough?

The IP market comes to terms with its biggest sale in years, but though the portfolio is said to be hitting all the right monetisation sweet spots questions abound about levels of interest and how high bids will go 

20 June 2019

Qualcomm judge set to preside over key Avanci auto case

San Jose based Judge Lucy Koh will hear challenge brought by Continental to platform’s licensing model   

03 June 2019

Shenzhen-based operating company tapped to license foreign pool's China rights

Netac’s own killer patent is set to expire later this year. But according to demand letters circulating Chinese media, the memory maker's IP team is now partnering with a patent pool formed by Panasonic, Toshiba and SanDisk

27 May 2019

New IP Bridge co-CEO talks licensing in China, Avanci’s prospects in Japan and company's 'next phase'

Minoru Fujiki (pictured, right) has taken charge of the fund operator’s patent business after the departure of founding CEO Shigeharu Yoshii (centre)

20 May 2019

After SEP push Unified Patents goes back to its roots

Cisco and McAfee among early members as launch of new security zone initiative reflects heightened NPE activity in the sector

13 May 2019

Continental lawsuit against Avanci could help set the terms for licensing in the IoT 

Key automotive supplier accuses pool operator, Nokia and several other patent owners of antitrust violations in what looks set to become a blockbuster case in front of the Northern California federal district court

09 May 2019

Spirit of collaboration in the air at IAM’s fourth Auto IP USA event

With the industry facing numerous competitive challenges, traditional operators are increasingly turning to partnerships with new and existing players in a dynamic that throws up numerous IP challenges  

02 May 2019

Avanci’s success suggests that patent pools have a bright future. If only the HEVC community would get the message

News that five more Volkswagen brands have signed up to the IoT platform underline strengths of a pooled approach in providing transparency and certainty to SEP licensing

15 April 2019

Five key takeaways from Avanci's breakthrough licensing deals with Audi and Porsche

From the importance of bringing Nokia on board to the prospects of an agreement with one of the major American or Japanese manufacturers, we tell you what you need to know about the news of the platform's German transactions

12 April 2019

Via Licensing signals China focus with new deals and big hires

In an interview with IAM, firm president Joe Siino (pictured, far right) also confirms expansion of operations in Hong Kong, with former Technicolor licensing head Deirdre Leane soon to join the team

26 March 2019

Top state life sciences R&D deal-maker explains how to overcome patent barriers to partnerships

A*STAR’s head of IP and corporate services Suresh Sachi sets out his approach to partnering with biopharma innovators, the exclusivity-related stumbling blocks – and how to overcome them